|
|
Volumn 80, Issue 3, 2001, Pages 170-173
|
|
Effective treatment with rituximab in a patient with refractory prolymphocytoid transformed B-chronic lymphocytic leukemia and Evans syndrome
a
|
|
Author keywords
Autoimmune hemolytic disease; CLL; Rituximab
|
|
Indexed keywords
ALEMTUZUMAB;
ALKYLATING AGENT;
ALLOPURINOL;
BENDAMUSTINE;
CD19 ANTIGEN;
CD20 ANTIGEN;
CD5 ANTIGEN;
CLADRIBINE;
CYCLOPHOSPHAMIDE;
EPIRUBICIN;
FLUDARABINE;
MONOCLONAL ANTIBODY;
PREDNISONE;
PURINE DERIVATIVE;
RITUXIMAB;
VINCRISTINE;
AGED;
ARTICLE;
AUTOIMMUNE HEMOLYTIC ANEMIA;
B CELL LEUKEMIA;
BLOOD;
CANCER GROWTH;
CANCER STAGING;
CASE REPORT;
CHILL;
CHRONIC LYMPHATIC LEUKEMIA;
CONTROLLED STUDY;
DRUG EFFICACY;
DRUG SAFETY;
FEVER;
HUMAN;
LYMPHOCYTE COUNT;
LYMPHOCYTE TRANSFORMATION;
LYMPHOCYTOSIS;
MALE;
PERIPHERAL LYMPHOCYTE;
PRIORITY JOURNAL;
PROLYMPHOCYTE;
SPLENOMEGALY;
THROMBOCYTE COUNT;
THROMBOCYTOPENIA;
AGED;
ANEMIA, HEMOLYTIC, AUTOIMMUNE;
ANTIBODIES, MONOCLONAL;
ANTINEOPLASTIC AGENTS;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
BONE MARROW;
HUMANS;
IMMUNOPHENOTYPING;
LEUKEMIA, LYMPHOCYTIC, CHRONIC;
MALE;
NITROGEN MUSTARD COMPOUNDS;
REMISSION INDUCTION;
TREATMENT FAILURE;
|
|
EID: 0035065041
PISSN: 09395555
EISSN: None
Source Type: Journal
DOI: 10.1007/s002770000251 Document Type: Article |
|
Times cited : (38)
|
|
References (14)
|
